1. Home
  2. TMCI vs SABS Comparison

TMCI vs SABS Comparison

Compare TMCI & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Treace Medical Concepts Inc.

TMCI

Treace Medical Concepts Inc.

HOLD

Current Price

$2.59

Market Cap

174.6M

Sector

Health Care

ML Signal

HOLD

Logo SAB Biotherapeutics Inc.

SABS

SAB Biotherapeutics Inc.

HOLD

Current Price

$3.98

Market Cap

181.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TMCI
SABS
Founded
2014
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
174.6M
181.4M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
TMCI
SABS
Price
$2.59
$3.98
Analyst Decision
Hold
Strong Buy
Analyst Count
6
3
Target Price
$6.87
$9.00
AVG Volume (30 Days)
777.8K
315.6K
Earning Date
11-06-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$218,879,000.00
$114,698.00
Revenue This Year
$3.25
N/A
Revenue Next Year
$1.07
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.90
N/A
52 Week Low
$2.44
$1.00
52 Week High
$10.79
$6.60

Technical Indicators

Market Signals
Indicator
TMCI
SABS
Relative Strength Index (RSI) 29.93 58.29
Support Level $2.64 $3.88
Resistance Level $2.76 $4.03
Average True Range (ATR) 0.20 0.26
MACD 0.09 -0.02
Stochastic Oscillator 27.17 83.33

Price Performance

Historical Comparison
TMCI
SABS

About TMCI Treace Medical Concepts Inc.

Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers and hospitals.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: